Valuation: Biogen Inc.

Market Cap 32.62B 28B 26.28B 24B 45.3B 3,111B 45.51B 311B 121B 1,570B 122B 120B 5,199B P/E 2026 *
39.2x
P/E 2027 * 19.3x
Enterprise Value 37.56B 32.23B 30.26B 27.63B 52.15B 3,582B 52.4B 358B 139B 1,807B 141B 138B 5,985B EV / Sales 2026 *
3.6x
EV / Sales 2027 * 3.29x
Free-Float
85.8%
Yield 2026 *
-
Yield 2027 * -
1 day+0.35%
1 week+0.08%
Current month+9.25%
1 month+10.79%
3 months+14.84%
6 months+17.93%
Current year+25.99%
1 week 213.96
Extreme 213.96
222.85
1 month 199.4
Extreme 199.4
222.85
Current year 160.36
Extreme 160.3645
222.85
1 year 131.52
Extreme 131.52
222.85
3 years 110.04
Extreme 110.035
270.5
5 years 110.04
Extreme 110.035
347.74
10 years 110.04
Extreme 110.035
468.55
Manager TitleAgeSince
Chief Executive Officer 66 14/11/2022
Director of Finance/CFO 60 01/03/2025
Chief Tech/Sci/R&D Officer - 28/10/2024
Director TitleAgeSince
Director/Board Member 69 23/03/2010
Director/Board Member 77 01/01/2010
Director/Board Member 72 19/06/2019
Date Insider Type Main position Quantity % Market Cap.
4/8/26 Sell

Director

-593 0.0004%
9/6/26 Free

Director

1,505 0.0010%
13/2/26 Free

Head of Human Resources

8,025 0.0055%
Change 5-day change 1-year change 3-year change Capi.($)
+0.30%+0.08%+62.18%-16.34% 32.62B
-1.26%-2.01%+40.20%-0.84% 83.24B
-7.16%-15.79%+493.81%+29.01% 63.41B
-0.69%+3.58%-19.85%-35.64% 59.49B
+0.76%+3.53%+0.08%+36.18% 52.94B
-1.38%+1.47%+10.64%+168.92% 49.86B
-0.69%+0.47%+53.67%+99.11% 26.29B
+9.69%+13.61%+9.85%+224.85% 22.23B
-1.15%-0.30%+60.29%+121.68% 17.22B
-0.45%-4.61%+63.86%+179.32% 15.72B
Average -0.18%+18.14%+77.47%+80.62% 42.3B
Weighted average by Cap. -1.04%+26.23%+93.88%+51.94%

Financials

2026 *2027 *
Net sales 10.44B 8.96B 8.41B 7.68B 14.5B 996B 14.57B 99.55B 38.58B 502B 39.21B 38.36B 1,664B 10.66B 9.15B 8.59B 7.84B 14.8B 1,017B 14.87B 102B 39.38B 513B 40.02B 39.15B 1,699B
Net income 953M 818M 768M 701M 1.32B 90.9B 1.33B 9.09B 3.52B 45.86B 3.58B 3.5B 152B 1.9B 1.63B 1.53B 1.4B 2.64B 181B 2.65B 18.11B 7.02B 91.39B 7.13B 6.98B 303B
Net Debt 4.94B 4.24B 3.98B 3.63B 6.86B 471B 6.89B 47.07B 18.24B 238B 18.54B 18.13B 787B 2.42B 2.08B 1.95B 1.78B 3.36B 231B 3.38B 23.07B 8.94B 116B 9.09B 8.89B 386B
Logo Biogen Inc.
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (72%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (7.4%) ; - other (20.6%): primarily revenues from partnership agreements.
Employees
7,500
Date Price Change Volume
27/08/26 US$221.74 +0.44% 294,363
25/08/26 US$220.77 +1.21% 495,435
24/08/26 US$218.12 +0.62% 649,828
21/08/26 US$216.78 +1.13% 722,347
20/08/26 US$214.35 -3.25% 808,625
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
35
Last Close Price
220.77USD
Average target price
236.22USD
Spread / Average Target
+7.00%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BIIB Stock